194 related articles for article (PubMed ID: 34382766)
21. Mutational analysis of a viral RNA element that counteracts rapid RNA decay by interaction with the polyadenylate tail.
Conrad NK; Shu MD; Uyhazi KE; Steitz JA
Proc Natl Acad Sci U S A; 2007 Jun; 104(25):10412-7. PubMed ID: 17563387
[TBL] [Abstract][Full Text] [Related]
22. A triple helix stabilizes the 3' ends of long noncoding RNAs that lack poly(A) tails.
Wilusz JE; JnBaptiste CK; Lu LY; Kuhn CD; Joshua-Tor L; Sharp PA
Genes Dev; 2012 Nov; 26(21):2392-407. PubMed ID: 23073843
[TBL] [Abstract][Full Text] [Related]
23. Regulation of MALAT1 triple helix stability and in vitro degradation by diphenylfurans.
Donlic A; Zafferani M; Padroni G; Puri M; Hargrove AE
Nucleic Acids Res; 2020 Aug; 48(14):7653-7664. PubMed ID: 32667657
[TBL] [Abstract][Full Text] [Related]
24. Targeting MALAT1 induces DNA damage and sensitize non-small cell lung cancer cells to cisplatin by repressing BRCA1.
Huang J; Lin C; Dong H; Piao Z; Jin C; Han H; Jin D
Cancer Chemother Pharmacol; 2020 Nov; 86(5):663-672. PubMed ID: 33030583
[TBL] [Abstract][Full Text] [Related]
25. Discovery of Small Molecule Ligands for MALAT1 by Tuning an RNA-Binding Scaffold.
Donlic A; Morgan BS; Xu JL; Liu A; Roble C; Hargrove AE
Angew Chem Int Ed Engl; 2018 Oct; 57(40):13242-13247. PubMed ID: 30134013
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of Japanese encephalitis virus replication by peptide nucleic acids targeting cis-acting elements on the plus- and minus-strands of viral RNA.
Yoo JS; Kim CM; Kim JH; Kim JY; Oh JW
Antiviral Res; 2009 Jun; 82(3):122-33. PubMed ID: 19428603
[TBL] [Abstract][Full Text] [Related]
27. Long non-coding RNA metastasis-associated lung adenocarcinoma transcript 1 regulates the expression of Gli2 by miR-202 to strengthen gastric cancer progression.
Zhang Y; Chen Z; Li MJ; Guo HY; Jing NC
Biomed Pharmacother; 2017 Jan; 85():264-271. PubMed ID: 27887846
[TBL] [Abstract][Full Text] [Related]
28. Mutual inhibition between YAP and SRSF1 maintains long non-coding RNA, Malat1-induced tumourigenesis in liver cancer.
Wang J; Wang H; Zhang Y; Zhen N; Zhang L; Qiao Y; Weng W; Liu X; Ma L; Xiao W; Yu W; Chu Q; Pan Q; Sun F
Cell Signal; 2014 May; 26(5):1048-59. PubMed ID: 24468535
[TBL] [Abstract][Full Text] [Related]
29. Knockdown of long non-coding RNA metastasis associated lung adenocarcinoma transcript 1 inhibits the proliferation and migration of bladder cancer cells by modulating the microRNA-34a/cyclin D1 axis.
Liu Y; Gao S; Du Q; Zhao Q
Int J Mol Med; 2019 Jan; 43(1):547-556. PubMed ID: 30387807
[TBL] [Abstract][Full Text] [Related]
30. Identification and Characterization of a Class of MALAT1-like Genomic Loci.
Zhang B; Mao YS; Diermeier SD; Novikova IV; Nawrocki EP; Jones TA; Lazar Z; Tung CS; Luo W; Eddy SR; Sanbonmatsu KY; Spector DL
Cell Rep; 2017 May; 19(8):1723-1738. PubMed ID: 28538188
[TBL] [Abstract][Full Text] [Related]
31. Multiassay Profiling of a Focused Small Molecule Library Reveals Predictive Bidirectional Modulation of the lncRNA MALAT1 Triplex Stability
Zafferani M; Martyr JG; Muralidharan D; Montalvan NI; Cai Z; Hargrove AE
ACS Chem Biol; 2022 Sep; 17(9):2437-2447. PubMed ID: 35984959
[TBL] [Abstract][Full Text] [Related]
32. Long non-coding RNA MALAT1 promotes proliferation and invasion via targeting miR-129-5p in triple-negative breast cancer.
Zuo Y; Li Y; Zhou Z; Ma M; Fu K
Biomed Pharmacother; 2017 Nov; 95():922-928. PubMed ID: 28915533
[TBL] [Abstract][Full Text] [Related]
33. Secondary Structural Model of Human MALAT1 Reveals Multiple Structure-Function Relationships.
McCown PJ; Wang MC; Jaeger L; Brown JA
Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31717552
[TBL] [Abstract][Full Text] [Related]
34. Natural antisense RNA promotes 3' end processing and maturation of MALAT1 lncRNA.
Zong X; Nakagawa S; Freier SM; Fei J; Ha T; Prasanth SG; Prasanth KV
Nucleic Acids Res; 2016 Apr; 44(6):2898-908. PubMed ID: 26826711
[TBL] [Abstract][Full Text] [Related]
35. Long non-coding RNAs: From disease code to drug role.
Chen Y; Li Z; Chen X; Zhang S
Acta Pharm Sin B; 2021 Feb; 11(2):340-354. PubMed ID: 33643816
[TBL] [Abstract][Full Text] [Related]
36. Long noncoding RNA MALAT1 as a potential therapeutic target in osteosarcoma.
Cai X; Liu Y; Yang W; Xia Y; Yang C; Yang S; Liu X
J Orthop Res; 2016 Jun; 34(6):932-41. PubMed ID: 26575981
[TBL] [Abstract][Full Text] [Related]
37. Long non‑coding RNA MALAT1 correlates with cell viability and mobility by targeting miR‑22‑3p in renal cell carcinoma via the PI3K/Akt pathway.
Li Z; Ma Z; Xu X
Oncol Rep; 2019 Feb; 41(2):1113-1121. PubMed ID: 30431104
[TBL] [Abstract][Full Text] [Related]
38. MALAT1 enhanced the proliferation of human osteoblasts treated with ultra‑high molecular weight polyethylene by targeting VEGF via miR‑22‑5p.
Yang X; Zhang Y; Li Y; Wen T
Int J Mol Med; 2018 Mar; 41(3):1536-1546. PubMed ID: 29328414
[TBL] [Abstract][Full Text] [Related]
39. Long Noncoding RNA MALAT1 Promotes Aggressive Pancreatic Cancer Proliferation and Metastasis via the Stimulation of Autophagy.
Li L; Chen H; Gao Y; Wang YW; Zhang GQ; Pan SH; Ji L; Kong R; Wang G; Jia YH; Bai XW; Sun B
Mol Cancer Ther; 2016 Sep; 15(9):2232-43. PubMed ID: 27371730
[TBL] [Abstract][Full Text] [Related]
40. The long noncoding RNA Malat1: Its physiological and pathophysiological functions.
Zhang X; Hamblin MH; Yin KJ
RNA Biol; 2017 Dec; 14(12):1705-1714. PubMed ID: 28837398
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
